Literature DB >> 16718752

Role of Helicobacter pylori in functional dyspepsia.

Colm O'Morain1.   

Abstract

The aetiology of dyspepsia is unknown in the majority of patients. Helicobacter pylori (H pylori) is the cause in a subset of patients. A non invasive test to assess the presence of H pylori is recommended in the management of patients under the age of 50 presenting to a family practitioner with dyspepsia. A urea breath test or a stool antigen test are the most reliable non invasive tests. Eradication of H pylori will reduce the risk to the patient with dyspepsia of developing a peptic ulcer, reduce the complication rate if prescribed non-steroid anti-inflammatory drugs and later reduce the risk of gastric cancer. The recommended treatment for non ulcer dyspepsia associated with a H pylori infection should be a 10-d course of treatment with a PPI and two antibiotics. Treatment efficacy should be assessed four weeks after completing treatment with a urea breath test or a stool antigen test.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16718752      PMCID: PMC4130974          DOI: 10.3748/wjg.v12.i17.2677

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

Review 1.  Nonulcer dyspepsia. Current concepts and management.

Authors:  D A Mc Namara; M Buckley; C A O'Morain
Journal:  Gastroenterol Clin North Am       Date:  2000-12       Impact factor: 3.806

2.  Is upper gastrointestinal radiography a cost-effective alternative to a Helicobacter pylori "test and treat" strategy for patients with suspected peptic ulcer disease?

Authors:  M Rich; J M Scheiman; W Tierney; A M Fendrick
Journal:  Am J Gastroenterol       Date:  2000-03       Impact factor: 10.864

3.  Helicobacter pylori eradication therapy: a discrepancy between current guidelines and clinical practice.

Authors:  J M Lee; E Deasy; C A O'Morain
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-04       Impact factor: 2.566

Review 4.  Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.

Authors:  P Moayyedi; S Soo; J Deeks; D Forman; J Mason; M Innes; B Delaney
Journal:  BMJ       Date:  2000-09-16

Review 5.  Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.

Authors:  P Malfertheiner; F Mégraud; C O'Morain; A P S Hungin; R Jones; A Axon; D Y Graham; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2002-02       Impact factor: 8.171

6.  Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients.

Authors:  N Broutet; S Tchamgoué; E Pereira; H Lamouliatte; R Salamon; F Mégraud
Journal:  Aliment Pharmacol Ther       Date:  2003-01       Impact factor: 8.171

7.  Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia.

Authors:  Wendy Hall; Martin Buckley; Paul Crotty; Colm A O'Morain
Journal:  Clin Gastroenterol Hepatol       Date:  2003-09       Impact factor: 11.382

8.  Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis.

Authors:  U Ladabaum; W D Chey; J M Scheiman; A M Fendrick
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

9.  Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.

Authors:  D McNamara; M Buckley; J Gilvarry; C O'Morain
Journal:  Helicobacter       Date:  2002-10       Impact factor: 5.753

10.  Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.

Authors:  N Chiba; S J O Veldhuyzen Van Zanten; S Escobedo; E Grace; J Lee; P Sinclair; A Barkun; D Armstrong; A B R Thomson
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171

View more
  5 in total

1.  Functional dyspepsia.

Authors:  Rita Brun; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 2.  Reassessment of functional dyspepsia: a topic review.

Authors:  Andrew Seng Boon Chua
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

Review 3.  Functional Dyspepsia: Diagnostic and Therapeutic Approaches.

Authors:  Gregory S Sayuk; C Prakash Gyawali
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

4.  Tibetan herbal formula Padma Digestin modulates gastrointestinal motility in vitro.

Authors:  Bruno M Balsiger; Magali Krayer; Andreas Rickenbacher; Beatrice Flogerzi; Cecile Vennos; Juergen M Gschossmann
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-02-06

5.  Investigating functional dyspepsia in Asia.

Authors:  Yeong Yeh Lee; Andrew Seng Boon Chua
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.